ranolazine (Q907104)

RANOLAZINE (English)

3 October 2016

C₂₄H₃₃N₃O₄

1 reference

RANOLAZINE (English)

19 November 2016

CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O

1 reference

https://www.whocc.no/atc_ddd_index/?code=C01EB18

RANOLAZINE (English)

19 November 2016

1.5 gram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

significant drug interaction

voriconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

posaconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

simvastatin

rhabdomyolysis

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

atorvastatin

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

itraconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Ranolazine

last update

20 May 2018

subject has role

xenobiotic-transporting ATPase inhibitor

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D000069458

15 March 2018

sodium channel blocker

1 reference

InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)

Medical Subject Headings

15 March 2018

Ranolazine

0 references

Identifiers

InChI

1 reference

RANOLAZINE (English)

19 November 2016

2 references

RANOLAZINE (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

95635-55-5

2 references

ranolazine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=95635-55-5

9 April 2021

1 reference

Ranolazine (English)

19 November 2016

2 references

RANOLAZINE (English)

19 November 2016

ChEBI ID

87690

mapping relation type

2 references

RANOLAZINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)

1 reference

RANOLAZINE (English)

19 November 2016

2 references

inferred from InChIKey

splash10-004i-1321900000-58e490b47155b2267ecc

1 reference

0 references

HSDB ID

7924

1 reference

Hazardous Substances Data Bank

28 October 2019

Ranolazine (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.149.259

27 December 2018

ECHA Substance Infocard ID

N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide (English)

quotation

CAS no.: 95635-55-5 (English)

100.149.259

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.149.259

27 December 2018

N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide (English)

quotation

CAS no.: 95635-55-5 (English)

1 reference

Guide to Pharmacology Ligand ID

Ranolazine (English)

publication date

17 November 2015

7291

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7291

ranolazine (English)

19 November 2016

Ranolazine

0 references

MeSH tree code

D02.065.199.092.850

0 references

D02.092.146.113.092.850

0 references

0 references

1 reference

ranolazine (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014388

2 references

based on heuristic

inferred from InChIKey

2 references

ranolazine (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

ranolazine (English)

19 November 2016

0 references

1 reference

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C0073633

1 reference